Salesforce's raised guidance lifts the stock but doesn't change our rating

Salesforce reported fiscal Q3 revenue of $10.26 billion, up 8.6% year‑over‑year and essentially flat to the LSEG consensus ($10.27B), while adjusted EPS came in at $3.25 (+35% YoY) versus a $2.86 estimate. Management raised FY26 revenue guidance to $41.45–41.55 billion (9–10% growth) and adjusted EPS to $11.75–11.77, citing an early close of the $8B Informatica deal (adding ~80bps to growth) and a strong cRPO outlook; Q4 revenue guidance is $11.13–11.23B with adj EPS $3.02–3.04. Key positives include Agentforce traction (ARR $540M, +330% YoY; >9,500 paid deals), double‑digit RPO expansion, improved margins and a $3.8B buyback in the quarter, but the slight sales miss and lingering AI‑disruption concerns temper upside, leading the author to maintain its rating and $300 price target.

Analysis

Market structure: Salesforce (CRM) is the near-term winner — Agentforce topline momentum (ARR $540M, +330% YoY) and raised FY26 guidance (revenue +9–10%; Informatica adding ~80bps) improve pricing power for platform services and expand cross-sell into large enterprise accounts. Competitors (MSFT, SAP) face pressure to match agentic automation; verticalized SMB players (HUBS) are more exposed where Marketing & Commerce softness sits. Strong cRPO guidance (+15% expected) signals demand re-acceleration for multi-year SaaS commitments and reduces revenue supply uncertainty for the next 12–18 months.

Risk assessment: Tail risks include AI regulatory action on data use (low-probability, high-impact), Informatica integration failure (mid-probability), and slower-than-expected Agentforce monetization (high-impact if ARR growth falls <100% YoY). Near-term (days–weeks) risk is an earnings-fade after the pop; medium-term (3–12 months) hinge on cRPO/organic growth excluding Informatica (watch organic growth <7% as a red flag); long-term (2–5 years) requires Agentforce to scale to multiple billions ARR to justify valuation expansion. Hidden dependencies: compute costs, enterprise data contracts, and existing-customer upsell durability (50% of Agentforce bookings from existing customers).

Trade implications: Tactical long exposure to CRM is attractive but should be risk-managed — use staggered entries and options to cap downside while keeping upside to a $300 target (12–18 months). Relative value: long CRM vs short HUBS (or trading HUBS’ marketing-cloud exposure) captures enterprise vs SMB divergence. Options: favor debit call spreads (6–12 month LEAPs) or buy-write structures to monetize buyback tailwinds while limiting capital at risk.

Contrarian angles: The market may underprice margin expansion from timing and bad-debt recoveries — if GAAP/adjusted margins sustain, CRM multiple could re-rate even before 10%+ organic growth. Conversely, guidance lift driven materially by the Informatica close (80–300bps across metrics) suggests the rally could be overdone if subsequent quarters revert to lower organic growth; historical parallels include acquisition-boosted guidance that faded the next two quarters. Watch unintended consequences: heavy buybacks reduce acquisition optionality and leave few levers if Agentforce adoption stalls.

Key Decisions for Investors

• Establish a 2–3% portfolio long in CRM via staggered cash purchases: 50% at market (~$245), add 25% on pullback to $225, final 25% on breach of $260 with target $300 within 12–18 months; hard stop-loss: trim if organic revenue growth (ex-Informatica) decelerates below 7% YoY or cRPO growth falls below 10% next quarter.
• Buy a limited-risk options spread: purchase Jan 2026 CRM 240C and sell Jan 2026 CRM 320C (size = 0.5% notional) to capture upside to $320 while capping premium; if CRM > $320 before Jan 2026, unwind the spread to realize gains.
• Pair trade: go long CRM (1.5% position) and short HUBS (0.75% position) to capture enterprise AI upsell vs SMB marketing weakness; tighten short if HUBS reports margin recovery or CRM Agentforce adoption stalls — reassess after next quarterly prints (within 90 days).
• Small thematic trade on Informatica integration: buy INFA 3–6 month call options (size = 0.25% notional) to play potential incremental bookings and data-integration cross-sell; cut if integration milestones (contract renewals or 2+ large joint deals) are not announced within 6 months.